Crossmark

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

Crossref DOI link: https://doi.org/10.1186/s12885-018-4678-x

Published Online: 2018-07-31

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pannier, Diane

Adenis, Antoine

Bogart, Emilie

Dansin, Eric

Clisant-Delaine, Stéphanie

Decoupigny, Emilie

Lesoin, Anne

Amela, Eric

Ducornet, Sandrine

Meurant, Jean-Pierre

Le Deley, Marie-Cécile

Penel, Nicolas http://orcid.org/0000-0001-5243-1548
License Information

Text and Data Mining valid from 2018-07-31
More Information

Article History

Received: 11 October 2017

Accepted: 18 July 2018

First Online: 31 July 2018

Ethics approval and consent to participate

: This study was approved by the regional Ethics Committee (“Comité de Protection des Patients Nord-Ouest III”, date of approval: 02 March 2011) and the French Health Products Safety Agency (“Agence Française de Sécurité Sanitaire et des Produits de Santé”, Date of 13 May 2011). This study was registered in the ExternalRef removed Register (NCT01374620). Written informed consent was obtained from each patient.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.